Rehab A. Abdullah

2.2k total citations
30 papers, 1.7k citations indexed

About

Rehab A. Abdullah is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Rehab A. Abdullah has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pharmacology, 15 papers in Cellular and Molecular Neuroscience and 8 papers in Cognitive Neuroscience. Recurrent topics in Rehab A. Abdullah's work include Cannabis and Cannabinoid Research (27 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Neuroscience and Neuropharmacology Research (8 papers). Rehab A. Abdullah is often cited by papers focused on Cannabis and Cannabinoid Research (27 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Neuroscience and Neuropharmacology Research (8 papers). Rehab A. Abdullah collaborates with scholars based in United States, Canada and United Kingdom. Rehab A. Abdullah's co-authors include Aron H. Lichtman, Benjamin F. Cravatt, Steven G. Kinsey, Jonathan Z. Long, Justin L. Poklis, Divya Ramesh, Dale L. Boger, Micah J. Niphakis, Dana E. Selley and Laura E. Wise and has published in prestigious journals such as Neuron, Brain Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Rehab A. Abdullah

30 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rehab A. Abdullah United States 24 1.5k 834 334 315 273 30 1.7k
Lamont Booker United States 8 1.6k 1.1× 746 0.9× 238 0.7× 350 1.1× 231 0.8× 10 1.8k
Divya Ramesh United States 17 1.2k 0.8× 555 0.7× 242 0.7× 229 0.7× 171 0.6× 34 1.4k
Akira Shinoda Japan 6 1.7k 1.1× 860 1.0× 167 0.5× 401 1.3× 202 0.7× 12 1.8k
Kristin Demarest United States 10 1.0k 0.7× 587 0.7× 208 0.6× 217 0.7× 166 0.6× 11 1.4k
Laura E. Wise United States 23 915 0.6× 722 0.9× 212 0.6× 271 0.9× 194 0.7× 34 1.5k
Marja D. Van Sickle Canada 8 1.5k 1.0× 771 0.9× 232 0.7× 429 1.4× 104 0.4× 10 1.7k
Paolo Urbani Italy 6 1.3k 0.9× 750 0.9× 155 0.5× 314 1.0× 100 0.4× 6 1.4k
T. P. Dinh United States 7 2.1k 1.4× 1.3k 1.5× 233 0.7× 606 1.9× 202 0.7× 7 2.3k
Eileen M. Briley United States 14 1.9k 1.3× 1.3k 1.5× 237 0.7× 348 1.1× 280 1.0× 15 2.6k
Darren Fegley United States 9 2.4k 1.7× 1.5k 1.8× 346 1.0× 603 1.9× 324 1.2× 10 2.8k

Countries citing papers authored by Rehab A. Abdullah

Since Specialization
Citations

This map shows the geographic impact of Rehab A. Abdullah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rehab A. Abdullah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rehab A. Abdullah more than expected).

Fields of papers citing papers by Rehab A. Abdullah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rehab A. Abdullah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rehab A. Abdullah. The network helps show where Rehab A. Abdullah may publish in the future.

Co-authorship network of co-authors of Rehab A. Abdullah

This figure shows the co-authorship network connecting the top 25 collaborators of Rehab A. Abdullah. A scholar is included among the top collaborators of Rehab A. Abdullah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rehab A. Abdullah. Rehab A. Abdullah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zidan, Ahmed, et al.. (2024). Expanding the Donor Pool to the Ultimate Level: Introducing the Revolutionary Hybrid Dual Graft Liver Transplant Using Domino and Living Donors. Transplantation Direct. 10(8). e1681–e1681. 1 indexed citations
2.
Wilkerson, Jenny L., Giulia Donvito, Travis W. Grim, et al.. (2017). Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide Inflammatory Pain Model. Journal of Pharmacology and Experimental Therapeutics. 363(3). 394–401. 22 indexed citations
3.
Wilkerson, Jenny L., Micah J. Niphakis, Travis W. Grim, et al.. (2016). The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model. Journal of Pharmacology and Experimental Therapeutics. 357(1). 145–156. 53 indexed citations
4.
Poklis, Justin L., Bogna M. Ignatowska‐Jankowska, Chiara Zanato, et al.. (2015). HPLC-MS-MS Determination of ZCZ-011, A Novel Pharmacological Tool for Investigation of the Cannabinoid Receptor in Mouse Brain Using Clean Screen FASt  Column Extraction. Journal of Analytical Toxicology. 39(5). 353–358. 5 indexed citations
5.
Smith, Tricia H., Lawrence C. Blume, Alex Straiker, et al.. (2015). Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation. Molecular Pharmacology. 87(4). 747–765. 48 indexed citations
6.
Ghosh, Sudeshna, Steven G. Kinsey, Qing-song Liu, et al.. (2015). Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice. Journal of Pharmacology and Experimental Therapeutics. 354(2). 111–120. 39 indexed citations
7.
Grim, Travis W., Robert A. Owens, Matthew F. Lazenka, et al.. (2014). Δ9-Tetrahydrocannabinol and Endocannabinoid Degradative Enzyme Inhibitors Attenuate Intracranial Self-Stimulation in Mice. Journal of Pharmacology and Experimental Therapeutics. 352(2). 195–207. 32 indexed citations
8.
Sexton, Michelle, Eiron Cudaback, Rehab A. Abdullah, et al.. (2014). Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. Inflammopharmacology. 22(5). 295–303. 23 indexed citations
9.
Kwilasz, Andrew J., Rehab A. Abdullah, Justin L. Poklis, Aron H. Lichtman, & S. Stevens Negus. (2014). Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats. Behavioural Pharmacology. 25(2). 119–129. 34 indexed citations
10.
Ignatowska‐Jankowska, Bogna M., Sudeshna Ghosh, Molly S. Crowe, et al.. (2013). In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. British Journal of Pharmacology. 171(6). 1392–1407. 103 indexed citations
11.
Kinsey, Steven G., Laura E. Wise, Divya Ramesh, et al.. (2013). Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects. Journal of Pharmacology and Experimental Therapeutics. 345(3). 492–501. 127 indexed citations
12.
Ramesh, Divya, Thomas F. Gamage, Tim Vanuytsel, et al.. (2013). Dual Inhibition of Endocannabinoid Catabolic Enzymes Produces Enhanced Antiwithdrawal Effects in Morphine-Dependent Mice. Neuropsychopharmacology. 38(6). 1039–1049. 60 indexed citations
13.
Limebeer, Cheryl L., Rehab A. Abdullah, Erin M. Rock, et al.. (2013). Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system. Psychopharmacology. 231(3). 603–612. 16 indexed citations
14.
Wise, Laura E., Kelly A. Long, Rehab A. Abdullah, et al.. (2012). Dual Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Blockade Produces THC-Like Morris Water Maze Deficits in Mice. ACS Chemical Neuroscience. 3(5). 369–378. 54 indexed citations
15.
Ritter, Joseph K., Cao Li, Min Xia, et al.. (2012). Production and Actions of the Anandamide Metabolite Prostamide E2 in the Renal Medulla. Journal of Pharmacology and Experimental Therapeutics. 342(3). 770–779. 39 indexed citations
16.
Oleson, Erik B., Michael Beckert, Carien S. Lansink, et al.. (2012). Endocannabinoids Shape Accumbal Encoding of Cue-Motivated Behavior via CB1 Receptor Activation in the Ventral Tegmentum. Neuron. 73(2). 360–373. 127 indexed citations
17.
Booker, Lamont, Steven G. Kinsey, Rehab A. Abdullah, et al.. (2011). The fatty acid amide hydrolase (FAAH) inhibitor PF‐3845 acts in the nervous system to reverse LPS‐induced tactile allodynia in mice. British Journal of Pharmacology. 165(8). 2485–2496. 94 indexed citations
18.
Thorpe, Andrew, Joel E. Schlosburg, Benjamin F. Cravatt, et al.. (2010). FAAH−/− Mice Display Differential Tolerance, Dependence, and Cannabinoid Receptor Adaptation After Δ9-Tetrahydrocannabinol and Anandamide Administration. Neuropsychopharmacology. 35(8). 1775–1787. 65 indexed citations
19.
Hoot, Michelle R., Laura J. Sim‐Selley, Justin L. Poklis, et al.. (2010). Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice. Brain Research. 1339. 18–25. 25 indexed citations
20.
Schlosburg, Joel E., Divya Ramesh, Rehab A. Abdullah, et al.. (2009). Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice. The AAPS Journal. 11(2). 342–352. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026